Resonetics has acquired the manufacturing assets, process know-how, and intellectual property related to implantable and external pulse generators (IPG/EPG) and leads manufacturing and assembly from Med-Ally.

Based in Charleston, S.C., Med-Ally is a medtech design and development company focused on the neuromodulation sector. This acquisition will strengthen Resonetics’ Medical Power business by merging its implantable battery technologies with advanced pulse generator manufacturing processes.

The integration allows Resonetics to provide a solution from energy source to active implantable device, serving the growing neuromodulation, brain-computer interface (BCI), and cardiac rhythm management (CRM) markets. As part of the transaction, the acquired assets will be transferred to an existing Resonetics facility.

“This acquisition represents an important step forward for our Bioelectronic market segment,” said Kevin Kelly, CEO of Resonetics. “We already provide implantable batteries that power neurostimulation and cardiac devices. Now we can manufacture the pulse generators themselves, giving customers a more integrated and efficient solution.”

This acquisition is the company’s third notable transaction in the last year. Resonetics added nitinol gun-drilling and insert- and micro-molding with the prior acquisitions of select assets from Medical Component Specialists and Eden Holdings last year.

“Combining IPG manufacturing & assembly with Resonetics’ implantable battery expertise creates a differentiated capability in the industry,” said Fred Borne, VP of Fiber Optic Sensors & Medical Power at Resonetics. “We’re now positioned to be the comprehensive partner for next-generation neuromodulation devices, something our customers have been seeking.”